The term HKAFO is stands for hip-knee-ankle-foot-orthosis and describes the parts of the body that this device encompasses. This device is a basically a KAFO with the addition of a hip joint and pelvic section. (Please review KAFO information] The HKFO is usually prescribed for patients with neuromuscular conditions affected by the absence or weakness of hip muscles. It helps for Standing and Ambulatory assistance. MOBILIS LOWER LIMB ORTHOTIC CLINIC is a proud clinical provider for such highly technical devices manufactured in the UAE.

RGO is a lightweight bracing system that gives structural stance phase support to the lower trunk and lower limbs of the patient with lower extremity paralysis. It uses a cable-coupling system to provide hip joint motion for the swing phase. In the RGO, via its cable system, flexion of one hip (in swing) results in extension of the other hip (concurrently in stance). The hip joints of the orthosis are coupled together using two Bowden cables to transmit the necessary forces (although the original design used a single cable, functional problems and subsequent revisions evolved into the use of a second cable). This reciprocal coupling has the added benefit of eliminating simultaneous hip flexion and reducing the risk of “jack knifing” during ambulation.

RGO prescribed for Children with myelomeningocele who had absence or weakness of the hip extensor mechanism, Adults and children with paraplegia and Children with the thoracic and high lumbar level of paralysis.

The addition of the hip joint and pelvic section provides control to selected hip motions. These selected motions of the hip are front to back, side to side, and rotation. One reason the hip section is added to a KAFO is to reduce or minimize the risk of the hip moving out of proper position or dislocating. Another common goal is to stabilize the pelvis and lower spine in cases where the patient is weak or paralyzed. This is designed for patients with high-level spinal cord dysfunction (congenital or traumatic) who would not otherwise be candidates for ambulation.

HKAFO is prescribed for patients with muscular dystrophy, spina bifida, cerebral palsy and traumatic injuries resulting in paraparesis or paraplegia.